Haemostatic defects in polycythaemia vera.
D000244:Adenosine Diphosphate / Q000378:metabolism / Q000494:pharmacology; D000328:Adult; D000368:Aged; D000991:Antithrombins / Q000032:analysis; D001772:Blood Cell Count; D001777:Blood Coagulation; D001779:Blood Coagulation Factors / Q000032:analysis; D001780:Blood Coagulation Tests; D001792:Blood Platelets / Q000503:physiopathology; D003018:Clot Retraction; D003094:Collagen / Q000494:pharmacology; D004211:Disseminated Intravascular Coagulation / Q000150:complications; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D005337:Fibrin / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis / Q000378:metabolism; D005342:Fibrinolysis; D006470:Hemorrhage / Q000150:complications; D006801:Humans; D008297:Male; D008875:Middle Aged; D010958:Plasminogen / Q000032:analysis; D010973:Platelet Adhesiveness / Q000187:drug effects; D011087:Polycythemia Vera / Q000097:blood* / Q000150:complications; D011517:Prothrombin Time; D013917:Thrombin / Q000494:pharmacology; D013924:Thrombophlebitis / Q000150:complications
D000991:Antithrombins; D001779:Blood Coagulation Factors; D000244:Adenosine Diphosphate; D005337:Fibrin; D005340:Fibrinogen; D010958:Plasminogen; D003094:Collagen; D013917:Thrombin; D004837:Epinephrine